• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者中程序性细胞死亡配体2阳性单核细胞来源的髓源性抑制细胞和程序性细胞死亡蛋白1阳性调节性T细胞减少:对免疫发病机制的影响

Decreased programmed cell death ligand 2-positive monocytic myeloid-derived suppressor cells and programmed cell death protein 1-positive T-regulatory cells in patients with type 2 diabetes: implications for immunopathogenesis.

作者信息

Liu Zhaoxiang, Zhang Mingqiang, Shi Xiaohu, Zhao Wenhui, Cao Chenxiang, Jin Lixia, Wang Yanlei, Xiao Jianzhong

机构信息

Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

出版信息

Endocr Connect. 2023 Aug 3;12(9):e230218. doi: 10.1530/EC-23-0218.

DOI:10.1530/EC-23-0218
PMID:37410080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10448569/
Abstract

OBJECTIVES

The activation of immune cells plays a significant role in the progression of type 2 diabetes. This study aimed to investigate the potential role of myeloid-derived suppressor cells (MDSCs) and T-regulatory cells (Tregs) in type 2 diabetes.

METHODS

A total of 61 patients diagnosed with type 2 diabetes were recruited. Clinical characteristics were reviewed and peripheral blood samples were collected. We calculated the percentage of different cells. Frequencies of MDSC subsets refered to the percentage of G-MDSCs (CD15+CD33+CD11b+CD14-HLA-DR-/low) in CD45 positive cells and the percentage of M-MDSCs (CD14+CD15-CD11b+CD33+HLA-DR-/low) in lymphocytes plus monocytes.

RESULTS

Frequencies of programmed cell death ligand 1-positive granulocytic MDSCs (PD-L1+ G-MDSCs), programmed cell death ligand 2-positive monocytic MDSCs (PD-L2+ M-MDSCs), PD-L2+ G-MDSC, and programmed cell death protein 1-positive Tregs (PD-1+Tregs) were decreased in patients with type 2 diabetes. The frequency of PD-1+ Tregs was positively related to PD-L2+ M-MDSCs (r= 0.357, P = 0.009) and negatively related to HbA1c (r = -0.265, P = 0.042), fasting insulin level (r = -0.260, P = 0.047), and waist circumference (r = -0.373, P = 0.005).

CONCLUSIONS

Decreased PD-L2+ M-MDSCs and PD-1+ Tregs may promote effector T cell activation, leading to chronic low-grade inflammation in type 2 diabetes. These findings highlight the contribution of MDSCs and Tregs to the immunopathogenesis of type 2 diabetes and suggest their potential as targets for new therapeutic approaches.

摘要

目的

免疫细胞的激活在2型糖尿病的进展中起重要作用。本研究旨在探讨髓系来源的抑制性细胞(MDSCs)和调节性T细胞(Tregs)在2型糖尿病中的潜在作用。

方法

共招募了61例诊断为2型糖尿病的患者。回顾临床特征并采集外周血样本。我们计算了不同细胞的百分比。MDSC亚群的频率指的是CD45阳性细胞中粒系MDSCs(G-MDSCs,CD15+CD33+CD11b+CD14-HLA-DR-/低)的百分比以及淋巴细胞加单核细胞中单核系MDSCs(M-MDSCs,CD14+CD15-CD11b+CD33+HLA-DR-/低)的百分比。

结果

2型糖尿病患者中程序性细胞死亡配体1阳性粒系MDSCs(PD-L1+ G-MDSCs)、程序性细胞死亡配体2阳性单核系MDSCs(PD-L2+ M-MDSCs)、PD-L2+ G-MDSC和程序性细胞死亡蛋白1阳性Tregs(PD-1+Tregs)的频率降低。PD-1+ Tregs的频率与PD-L2+ M-MDSCs呈正相关(r = 0.357,P = 0.009),与糖化血红蛋白(HbA1c)、空腹胰岛素水平和腰围呈负相关(r分别为-0.265,P = 0.042;r = -0.260,P = 0.047;r = -0.373,P = 0.005)。

结论

PD-L2+ M-MDSCs和PD-1+ Tregs的减少可能促进效应T细胞的激活,导致2型糖尿病中的慢性低度炎症。这些发现突出了MDSCs和Tregs对2型糖尿病免疫发病机制的作用,并提示它们作为新治疗方法靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/0e524ca158ea/EC-23-0218fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/e1b10c77e2c2/EC-23-0218fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/752898771b98/EC-23-0218fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/ef81ff61dec0/EC-23-0218fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/dd4c8b75894c/EC-23-0218fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/07bfa1978fe8/EC-23-0218fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/f41dae8d8418/EC-23-0218fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/a3b18c28b0c1/EC-23-0218fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/0e524ca158ea/EC-23-0218fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/e1b10c77e2c2/EC-23-0218fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/752898771b98/EC-23-0218fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/ef81ff61dec0/EC-23-0218fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/dd4c8b75894c/EC-23-0218fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/07bfa1978fe8/EC-23-0218fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/f41dae8d8418/EC-23-0218fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/a3b18c28b0c1/EC-23-0218fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f139/10448569/0e524ca158ea/EC-23-0218fig8.jpg

相似文献

1
Decreased programmed cell death ligand 2-positive monocytic myeloid-derived suppressor cells and programmed cell death protein 1-positive T-regulatory cells in patients with type 2 diabetes: implications for immunopathogenesis.2型糖尿病患者中程序性细胞死亡配体2阳性单核细胞来源的髓源性抑制细胞和程序性细胞死亡蛋白1阳性调节性T细胞减少:对免疫发病机制的影响
Endocr Connect. 2023 Aug 3;12(9):e230218. doi: 10.1530/EC-23-0218.
2
Recruitment of myeloid‑derived suppressor cells and regulatory T‑cells is associated with the occurrence of acute myocardial infarction.髓源性抑制细胞和调节性T细胞的募集与急性心肌梗死的发生有关。
Biomed Rep. 2023 Jul 17;19(2):55. doi: 10.3892/br.2023.1637. eCollection 2023 Aug.
3
The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.稳定期 COPD 患者外周血中程序性死亡受体-1/PD-L1 轴、髓系来源的抑制细胞亚群和调节性 T 细胞的临床相关性。
PeerJ. 2024 Mar 27;12:e16988. doi: 10.7717/peerj.16988. eCollection 2024.
4
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.CD4 + T效应记忆细胞功能障碍与胶质母细胞瘤患者中粒细胞性髓源性抑制细胞的积累有关。
Neuro Oncol. 2016 Jun;18(6):807-18. doi: 10.1093/neuonc/nov280. Epub 2015 Nov 17.
5
Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.蜕膜衍生粒细胞巨噬细胞集落刺激因子诱导循环 CD15+中性粒细胞中的多形核髓系来源抑制细胞。
Hum Reprod. 2020 Dec 1;35(12):2677-2691. doi: 10.1093/humrep/deaa217.
6
Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.循环肿瘤细胞上皮-间充质转化异质性及其与 HER2 阴性转移性乳腺癌患者骨髓来源抑制性细胞和调节性 T 细胞的相关性。
Anticancer Res. 2021 Feb;41(2):661-670. doi: 10.21873/anticanres.14817.
7
Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.人脾髓源抑制性细胞:表型和聚类分析。
Cell Immunol. 2021 May;363:104317. doi: 10.1016/j.cellimm.2021.104317. Epub 2021 Mar 1.
8
IFN-γ decreased the suppressive function of CD33HLA-DR myeloid cells through down-regulation of PD-1/PD-L2 signaling pathway.IFN-γ 通过下调 PD-1/PD-L2 信号通路降低 CD33HLA-DR 髓系细胞的抑制功能。
Mol Immunol. 2018 Feb;94:107-120. doi: 10.1016/j.molimm.2017.10.009. Epub 2018 Jan 4.
9
Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.外周髓源性抑制细胞和调节性T细胞PD-1阳性细胞可预测直肠癌患者对新辅助短程放疗的反应。
Oncotarget. 2015 Apr 10;6(10):8261-70. doi: 10.18632/oncotarget.3014.
10
CD33 CD14 CD11b HLA-DR monocytic myeloid-derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis.CCR9/CCL25 招募和激活的 CD33+CD14+CD11b+HLA-DR 单核细胞来源的髓系抑制细胞对于子宫内膜异位症的发病机制至关重要。
Am J Reprod Immunol. 2019 Jan;81(1):e13067. doi: 10.1111/aji.13067. Epub 2018 Nov 16.

引用本文的文献

1
Myeloid-Derived Suppressor Cells (MDSCs) and Obesity-Induced Inflammation in Type 2 Diabetes.髓源性抑制细胞(MDSCs)与2型糖尿病中的肥胖诱导炎症
Diagnostics (Basel). 2024 Nov 1;14(21):2453. doi: 10.3390/diagnostics14212453.

本文引用的文献

1
MDSC: Markers, development, states, and unaddressed complexity.骨髓来源抑制细胞:标志物、分化、状态和未解决的复杂性。
Immunity. 2021 May 11;54(5):875-884. doi: 10.1016/j.immuni.2021.04.004.
2
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.1 型糖尿病中的髓系来源的抑制性细胞是一个扩增的群体,表现出不同的 T 细胞抑制机制。
PLoS One. 2020 Nov 18;15(11):e0242092. doi: 10.1371/journal.pone.0242092. eCollection 2020.
3
Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
髓系来源的抑制细胞的早期激活通过 PD-L1/PD-1 轴参与脓毒症诱导的免疫抑制。
Front Immunol. 2020 Jul 3;11:1299. doi: 10.3389/fimmu.2020.01299. eCollection 2020.
4
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.中国 2018 年美国糖尿病协会诊断标准下的中国大陆糖尿病患病率:全国横断面研究。
BMJ. 2020 Apr 28;369:m997. doi: 10.1136/bmj.m997.
5
Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.调节性 T 细胞上的免疫检查点分子作为头颈部鳞状细胞癌的潜在治疗靶点。
Cancer Sci. 2020 Jun;111(6):1943-1957. doi: 10.1111/cas.14422. Epub 2020 May 19.
6
The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy.PD-1/PD-L1轴在调节性T细胞发育和功能中的作用:对癌症免疫治疗的启示
Onco Targets Ther. 2019 Oct 15;12:8437-8445. doi: 10.2147/OTT.S221340. eCollection 2019.
7
Regulatory T Cells: Pathophysiological Roles and Clinical Applications.调节性T细胞:病理生理作用及临床应用
Keio J Med. 2020 Mar 25;69(1):1-15. doi: 10.2302/kjm.2019-0003-OA. Epub 2019 Jul 26.
8
Administration of cytokine-induced myeloid-derived suppressor cells ameliorates renal fibrosis in diabetic mice.细胞因子诱导的髓源抑制细胞的给药可改善糖尿病小鼠的肾纤维化。
Stem Cell Res Ther. 2018 Jul 4;9(1):183. doi: 10.1186/s13287-018-0915-0.
9
Myeloid-derived suppressor cells suppress CD4+ T cell activity and prevent the development of type 2 diabetes.髓源性抑制细胞抑制 CD4+T 细胞的活性,防止 2 型糖尿病的发生。
Acta Biochim Biophys Sin (Shanghai). 2018 Apr 1;50(4):362-369. doi: 10.1093/abbs/gmy014.
10
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.二甲双胍诱导的 CD39 和 CD73 减少可阻断卵巢癌患者骨髓来源的抑制性细胞的活性。
Cancer Res. 2018 Apr 1;78(7):1779-1791. doi: 10.1158/0008-5472.CAN-17-2460. Epub 2018 Jan 26.